Wei Xu
8PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 30, 2026
Potent in vitro synergistic antiviral effects of the pan-coronavirus fusion inhibitor EK1 in combination with RBD-specific antibodies or Mpro inhibitors.Ruixue Xiu, Yuanzhou Wang, Wenbo Cai
|Apr 08, 2024
Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor.Najing Cao, Yanxing Cai, Xin Huang
|Sep 23, 2022
Chemically Modified Bovine β-Lactoglobulin as a Broad-Spectrum Influenza Virus Entry Inhibitor with the Potential to Combat Influenza Outbreaks.Yuhong Fu, Peiyu Li, Wei Xu
|Sep 23, 2021
An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope.Zezhong Liu, Wei Xu, Zhenguo Chen
|Jun 05, 2020
An amphipathic peptide targeting the gp41 cytoplasmic tail kills HIV-1 virions and infected cells.Qian Wang, Shan Su, Jing Xue
|Apr 17, 2019
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.Shuai Xia, Lei Yan, Wei Xu
Pageof 2
